Foley
& Lardner will be offering a web conference entitled "Lessons from the
Inaugral Year of New Post-Grant Patent Office Proceedings: What Separates the
Winners from the Losers?" on September 10, 2013 from 1:00 to 2:00 pm (Eastern).  Featured panelists for the web conference
will include C. Edward Polk, Jr., Chief Litigation Officer at Exela Pharma
Sciences, LLC (former USPTO Associate Solicitor); Andrew S. Baluch of Foley
& Lardner LLP (former expert legal advisor to the Under-Secretary &
Director of the USPTO); and Stephen B. Maebius of Foley & Lardner LLP.  Topics to be covered in the web conference
will include:

•
How will Fresenius v. Baxter (Fed.
Cir. 2013) impact post-grant proceedings?
•
Coordinating parallel litigation, post-grant proceedings, and ex parte
prosecution;
•
What circumstances would make IPR/CBM/PGR a particularly effective arsenal in
offensive or defensive strategy?
•
Top 10 lessons gleaned from case proceedings to date and implications; and
•
Discovery and estoppel implications.

While there is no cost to participate in the
program, pre-registration is required.  Those
interested in attending the webinar can register here.